- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x UD1: URIDINE-DIPHOSPHATE-N-ACETYLGLUCOSAMINE(Non-covalent)
- 9 x ACT: ACETATE ION(Non-functional Binders)
ACT.2: 8 residues within 4Å:- Chain A: Y.84, V.87, K.88, S.110, L.111, P.112, G.113
- Chain D: R.340
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain D- Hydrophobic interactions: A:Y.84, A:V.87
- Hydrogen bonds: A:Y.84, A:G.113
- Salt bridges: D:R.340
ACT.3: 4 residues within 4Å:- Chain A: R.267, I.273, E.274, T.275
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:I.273, A:T.275, A:T.275
ACT.4: 5 residues within 4Å:- Chain A: A.363, Q.364, T.386, V.388
- Chain D: E.140
1 PLIP interactions:1 interactions with chain A- Water bridges: A:Q.364
ACT.5: 3 residues within 4Å:- Chain A: T.324, N.350
- Chain C: E.348
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain C- Hydrogen bonds: A:N.350, C:E.348
ACT.11: 4 residues within 4Å:- Chain B: T.326, I.327, E.329
- Ligands: UD1.10
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:E.329, B:E.329
- Salt bridges: B:K.160
ACT.16: 4 residues within 4Å:- Chain C: P.256, D.257, G.276, E.277
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:D.257
- Hydrogen bonds: C:D.257, C:D.257
ACT.17: 6 residues within 4Å:- Chain C: K.160, V.161, P.298, I.327
- Chain D: R.295
- Ligands: UD1.15
5 PLIP interactions:1 interactions with chain D, 4 interactions with chain C- Salt bridges: D:R.295
- Hydrophobic interactions: C:P.298, C:I.327
- Hydrogen bonds: C:V.161
- Water bridges: C:T.326
ACT.23: 4 residues within 4Å:- Chain D: Q.7, G.8, T.10, N.412
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:N.412
- Hydrogen bonds: D:N.412
ACT.24: 4 residues within 4Å:- Chain D: Q.108, E.140, Y.142, K.144
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:Q.108
- Salt bridges: D:K.144
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.6: 7 residues within 4Å:- Chain A: R.91, I.94, W.95, R.120, H.125, G.164
- Ligands: UD1.1
Ligand excluded by PLIPEDO.7: 6 residues within 4Å:- Chain A: V.161, V.163, E.188, P.298, I.327
- Ligands: UD1.1
Ligand excluded by PLIPEDO.8: 5 residues within 4Å:- Chain A: D.260, L.263, A.264, R.267
- Chain B: H.155
Ligand excluded by PLIPEDO.9: 5 residues within 4Å:- Chain A: D.193, N.196, Y.226, L.229, Q.255
Ligand excluded by PLIPEDO.12: 7 residues within 4Å:- Chain B: R.91, A.92, W.95, R.120, H.125, G.164
- Ligands: UD1.10
Ligand excluded by PLIPEDO.13: 8 residues within 4Å:- Chain B: K.22, L.26, D.49, M.90, R.91, A.92, R.397
- Ligands: UD1.10
Ligand excluded by PLIPEDO.14: 6 residues within 4Å:- Chain B: V.192, D.193, N.196, Y.226, L.229, Q.255
Ligand excluded by PLIPEDO.18: 6 residues within 4Å:- Chain C: A.92, W.95, R.120, H.125, G.164
- Ligands: UD1.15
Ligand excluded by PLIPEDO.19: 4 residues within 4Å:- Chain C: T.52, K.55, L.86, T.89
Ligand excluded by PLIPEDO.20: 5 residues within 4Å:- Chain C: V.192, D.193, N.196, Y.226, Q.255
Ligand excluded by PLIPEDO.21: 3 residues within 4Å:- Chain C: T.17, R.252, N.253
Ligand excluded by PLIPEDO.25: 8 residues within 4Å:- Chain D: R.91, A.92, W.95, R.120, H.125, G.164
- Ligands: UD1.22, EDO.31
Ligand excluded by PLIPEDO.26: 9 residues within 4Å:- Chain D: K.22, L.26, D.49, R.91, A.92, L.370, R.397
- Ligands: UD1.22, EDO.31
Ligand excluded by PLIPEDO.27: 5 residues within 4Å:- Chain D: V.161, E.188, P.298, I.327
- Ligands: UD1.22
Ligand excluded by PLIPEDO.28: 5 residues within 4Å:- Chain D: I.244, E.358, K.359, L.360, I.382
Ligand excluded by PLIPEDO.29: 5 residues within 4Å:- Chain D: R.150, L.175, A.176, E.177, V.218
Ligand excluded by PLIPEDO.30: 8 residues within 4Å:- Chain A: R.340
- Chain D: Y.84, V.87, K.88, S.110, L.111, P.112, G.113
Ligand excluded by PLIPEDO.31: 6 residues within 4Å:- Chain D: K.22, R.120, L.370
- Ligands: UD1.22, EDO.25, EDO.26
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhu, J.Y. et al., Functional Consequence of Covalent Reaction of Phosphoenolpyruvate with UDP-N-acetylglucosamine 1-Carboxyvinyltransferase (MurA). J.Biol.Chem. (2012)
- Release Date
- 2012-03-07
- Peptides
- UDP-N-acetylglucosamine 1-carboxyvinyltransferase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x UD1: URIDINE-DIPHOSPHATE-N-ACETYLGLUCOSAMINE(Non-covalent)
- 9 x ACT: ACETATE ION(Non-functional Binders)
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhu, J.Y. et al., Functional Consequence of Covalent Reaction of Phosphoenolpyruvate with UDP-N-acetylglucosamine 1-Carboxyvinyltransferase (MurA). J.Biol.Chem. (2012)
- Release Date
- 2012-03-07
- Peptides
- UDP-N-acetylglucosamine 1-carboxyvinyltransferase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D